CliffBio
small molecule

TRIAMCINOLONE ACETONIDE

TRIAMCINOLONE ACETONIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRIAMCINOLONE ACETONIDE
Active ingredientTRIAMCINOLONE ACETONIDE
Strength0.055MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalJanuary 2023
Marketing statusOTC

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.